Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus

AIMS: LY2963016 (LY IGlar) and Lantus (IGlar) are insulin glargine products manufactured by distinct processes, but with identical amino acid sequences. This study compared the duration of action of LY IGlar and IGlar in subjects with type 1 diabetes mellitus (T1DM). MATERIALS AND METHODS: This was...

Descripción completa

Detalles Bibliográficos
Autores principales: Linnebjerg, Helle, Lam, Eric Chen Quin, Zhang, Xin, Seger, Mary E., Coutant, David, Chua, Laiyi, Kapitza, Christoph, Heise, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215447/
https://www.ncbi.nlm.nih.gov/pubmed/27484286
http://dx.doi.org/10.1111/dom.12759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215447/
https://www.ncbi.nlm.nih.gov/pubmed/27484286
http://dx.doi.org/10.1111/dom.12759

Ejemplares similares